CNE100001BC7
CNE100001BC7
HAISCO PHARMA
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 4.387.785.982 | 3.721.349.235 | 17.9% |
| Cost of Revenue | 1.265.234.158 | 1.061.971.989 | 19.1% |
| Gross Profit | 3.122.551.824 | 2.659.377.246 | 17.4% |
| 2.798.708.322 | 2.200.101.312 | 27.2% | |
| Operating Income | 323.843.502 | 459.275.934 | 29.5% |
| Pretax Income | 273.580.113 | 462.949.587 | 40.9% |
| Net Income Common Stockholders | 259.579.780 | 395.455.240 | 34.4% |
| -- | -- | -- | |
| -- | -- | -- |